EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling

附錄99.1

毅博科技諮詢報告2024財政年第三季度財務業績

2024年10月24日,加州門洛帕克(MENLO PARK)(GLOBE NEWSWIRE)- Exponent, Inc.(納斯達克股票代碼:EXPO)今天報告了截至2024年9月27日的2024財年第三季度財務業績。

毅博科技諮詢連續三個季度實現了年度利用率顯著提高,這反映了我們持續關注有效的資源管理和與市場需求的配合。正如預期的那樣,第三季度的營收在扣除退款之前與去年持平,但我們的淨利潤增長了6%,並擴大了我們的EBITDA利潤率。1 主動參與消費電子-半導體行業的增加到了健康水平,受益於增加的用戶體驗研究和產品開發諮詢。這在很大程度上被化學品-化學品行業中的持續挑戰和去年第三季度反應服務增長逾20%的高基準所抵消。我們多元化投資組合的固有實力繼續在充滿活力的運營環境中提供穩定性,董事長兼首席執行官凱瑟琳·科里根博士如是說。

「隨着行業以極快的速度轉型,創新與安全、健康和環保母基影響之間的關係變得日益複雜。這些問題是全球優先事項,強調了我們關鍵的見解和專業知識的必要性。展望未來,我們致力於增加人才和擴大我們的能力,以滿足客戶在各行業和產品生命週期中的需求,」 Corrigan博士繼續說道。

第三季度財務業績

2024年第三季度總收入和減除報銷前收入分別增長2%至13630萬美元,較2023年第三季度的13330萬美元和12500萬美元略有增長。

淨利潤在2024年第三季度增加到2600萬美元,每股稀釋後0.50美元,而2023年同期爲2450萬美元,每股稀釋後0.48美元。與2023年同期相比,2024年第三季度與基於股權激勵的獎勵相關的稅收調整分類的稅收效益爲50萬美元,在2023年第三季度微不足道。包括稅收效益在內,毅博科技諮詢的綜合稅率爲第三季度的27.5%,而2023年同期爲27.9%。

EBITDA1 2024年第三季度,費用增加至3580萬美元,佔收入前退款的28.6%,相比之下,2023年第三季度的費用爲3450萬美元,佔收入前退款的27.6%。

年度至今的財務結果

2024年前三個季度的總收入和扣除報銷前的收入分別增長了2%至42170萬美元和3%至39470萬美元,與2023年同期的41390萬美元和38330萬美元相比。

截至2024年前三季度,淨利潤爲8540萬元,每股攤薄收益爲1.66美元,而2023年同期爲7940萬元,每股攤薄收益爲1.54美元。與一年前相比,2024年前三季度實現的與股份獎勵相關的稅收調整分類稅收益爲220萬元,而一年前同期爲360萬元。考慮到稅收益,毅博科技諮詢截至2024年前三季度的綜合稅率爲26.4%,而去年同期爲24.9%。

EBITDA1 2024年前三個季度,非補償收入增至11580萬美元,佔營收的29.3%,相比之下,2023年同期爲10710萬美元,佔營收的27.9%。

在今天的一次單獨的新聞發佈中,毅博科技諮詢宣佈其每股分紅派息爲0.28美元,將於2024年12月20日支付,並重申其繼續支付季度分紅的意圖。2024年前三個季度,毅博科技諮詢支付了4400萬美元的股息,並以21970萬美元的現金及現金等價物收尾。

業務概況

毅博科技諮詢的工程和其他科學板塊在2024年第三季度以及前三個季度中佔公司營收的84%,此板塊在第三季度營收(未扣除返還款項前)較去年同期增長1%,在前三個季度中增長4%。增長的動力來自消費電子-半導體板塊活動的增加以及公用事業板塊需求的增強。

毅博科技諮詢的環保母基和健康領域在第三季度和2024年前三個季度的公司營收中佔比16%。與去年同期相比,該部門在第三季度和2024年前三個季度的營收在補償前減少了6%,在化學和生命科學行業遇到逆風的影響下。

業務展望
「我們的經營模式能夠與市場需求保持一致,導致2024年前九個月的利用率達到75%,盈利能力不斷擴大。我們對爲我們服務的各個行業的市場機會感到鼓舞,我們的招聘活動正在增加,我們正在戰略性地建立我們多樣化的人才和能力組合,」 致富金融(臨時代碼)和首席財務官Richard Schlenker評論說。「隨着我們結束2024年,我們將維持我們的營業收入指導,並提高全年的盈利指導。」

2024年第四季度,與前一年同期相比,毅博科技諮詢預計:

  • 收入在扣除報銷費用前將增長中單位數;
  • EBITDA1 將佔報銷費用前收入的23.5%至24.5%。

對於2024財政年,毅博科技諮詢預期,相較於前一年同期(包括額外的一週影響):

  • 收入在未扣除報銷前將增長低至中個位數;和,
  • EBITDA1 佔收入在未扣除報銷前的27.9%至28.1%。

毅博科技諮詢在引領創新和科技中的複雜性方面做得非常出色。我們對長期需求推動因素感到鼓舞,這加大了對我們不同能力和關鍵洞察力的需求。我們的重點仍然是預見客戶在產品生命週期中的不斷變化的需求,同時實現持續盈利增長,併爲股東創造持久價值,Corrigan博士總結道。

今日電話會議信息

毅博科技諮詢將於2024年10月24日星期四舉行業績電話會議,從東部時間下午4:30 / 太平洋時間下午1:30開始。 可通過撥打(844) 481-2781或(412) 317-0672來收聽電話會議。 電話會議的錄音可以在公司網站www.exponent.com/investors的投資者關係部分上進行網絡直播。 對於無法收聽網絡直播的人,電話會議的重播也將在Exponent網站上提供,或者可以撥打(877) 344-7529或(412) 317-0088,並輸入密碼1389454#。

Use of non-GAAP Financial Measures 1

EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation, and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income, and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present, and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position, or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.

Exponent has provided its outlook regarding EBITDA as a percentage of revenues before reimbursements. The Company has not reconciled this non-GAAP financial measure to the corresponding GAAP financial measure because guidance for the various reconciling items is not provided and the Company is unable to estimate with reasonable certainty the effect of these items without unreasonable effort. For example, the Company is unable to estimate with reasonable certainty the impact of equity awards on Exponent’s taxes without unreasonable effort. These items are uncertain, depend on various factors, and may have a material effect on Exponent’s results computed in accordance with GAAP. A reconciliation between the historical GAAP and non-GAAP financial measures presented in this release is provided in the financial tables at the end of this release.

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

Forward Looking Statements

This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

Source: Exponent, Inc.

  
  
EXPONENT, INC.  
CONDENSED CONSOLIDATED STATEMENTS OF INCOME 
For the Quarters Ended September 27, 2024 and September 29, 2023 
(unaudited) 
(in thousands, except per share data) 
           
       Quarter Ended Nine Months Ended 
       September 27, September 29, September 27, September 29, 
        2024  2023   2024  2023 
               
Revenues            
 Revenues before reimbursements $125,085 $124,959  $394,726 $383,317 
 Reimbursements    11,194  8,377   27,022  30,549 
               
  Revenues    136,279  133,336   421,748  413,866 
               
Operating expenses           
 Compensation and related expenses  81,954  74,011   251,747  241,028 
 Other operating expenses   11,975  10,997   33,691  30,863 
 Reimbursable expenses   11,194  8,377   27,022  30,549 
 General and administrative expenses  5,309  6,018   16,984  18,498 
               
        110,432  99,403   329,444  320,938 
               
  Operating income   25,847  33,933   92,304  92,928 
               
Other income (expense), net           
 Interest income, net   2,559  1,858   7,416  5,221 
 Miscellaneous income (expense), net  7,531  (1,774)  16,322  7,659 
        10,090  84   23,738  12,880 
               
  Income before income taxes  35,937  34,017   116,042  105,808 
               
Income taxes     9,893  9,479   30,629  26,398 
               
               
  Net income   $26,044 $24,538  $85,413 $79,410 
               
               
Net income per share:          
 Basic    $0.51 $0.48  $1.67 $1.55 
 Diluted    $0.50 $0.48  $1.66 $1.54 
               
Shares used in per share computations:         
 Basic     51,177  51,203   51,098  51,197 
 Diluted     51,622  51,645   51,527  51,680 
               


EXPONENT, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
September 27, 2024 and December 29, 2023
(unaudited)
(in thousands)
          
       September 27, December 29,
        2024   2023 
   Assets     
Current assets:      
 Cash and cash equivalents  $219,708  $187,150 
 Accounts receivable, net   168,618   167,360 
 Prepaid expenses and other assets  24,255   25,022 
  Total current assets   412,581   379,532 
Property, equipment and leasehold improvements, net  72,862   75,318 
Operating lease right-of-use asset  75,797   24,600 
Goodwill    8,607   8,607 
Other assets    174,218   158,720 
       $744,065  $646,777 
          
   Liabilities and Stockholders' Equity    
Current liabilities:      
 Accounts payable and accrued liabilities $22,646  $22,125 
 Accrued payroll and employee benefits  96,738   111,773 
 Deferred revenues    13,414   21,709 
 Operating lease liability   4,940   6,302 
  Total current liabilities  137,738   161,909 
Other liabilities    120,131   106,824 
Operating lease liability   75,922   21,959 
  Total liabilities   333,791   290,692 
          
Stockholders' equity:      
 Common stock    66   66 
 Additional paid-in capital   342,301   321,448 
 Accumulated other comprehensive loss  (1,606)  (2,977)
 Retained earnings    614,991   574,082 
 Treasury stock, at cost   (545,478)  (536,534)
   Total stockholders' equity  410,274   356,085 
       $744,065  $646,777 
          


EXPONENT, INC.
EBITDA and EBITDAS (1)
For the Quarters Ended September 27, 2024 and September 29, 2023
(unaudited)
(in thousands)
              
       Quarter Ended Nine Months Ended
       September 27, September 29, September 27, September 29,
        2024   2023   2024   2023 
              
Net Income    $26,044  $24,538  $85,413  $79,410 
              
Add back (subtract):          
              
 Income taxes    9,893   9,479   30,629   26,398 
 Interest income, net   (2,559)  (1,858)  (7,416)  (5,221)
 Depreciation and amortization  2,389   2,361   7,199   6,535 
              
  EBITDA (1)    35,767   34,520   115,825   107,122 
              
 Stock-based compensation   5,465   4,891   18,382   17,177 
              
  EBITDAS (1)  $41,232  $39,411  $134,207  $124,299 
              
              
(1) EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.